• Bsa I (RNase-free): Practical DNA Cleavage Guide

  2026-09-01

  Bsa I (RNase-free) provides sequence-directed cleavage for DNA manipulation, gene cloning, and other recombinant DNA workflows where RNA preservation is important. It is intended for molecular biology research only and should not be used for diagnostic, clinical, or medical applications.

• Carbenoxolone disodium: Protocol & QC

  2026-09-01

  Carbenoxolone disodium is an 11β-hydroxysteroid dehydrogenase inhibitor for controlled studies of glucocorticoid access, corticosterone metabolism, and gap junction communication. Use it in defined cell, enzyme, or tissue workflows with matched vehicles and orthogonal controls; do not treat it as a selective in vivo efficacy probe or a stand-alone basis for clinical interpretation.

• EdU Imaging Kits for HCC Proliferation

  2026-08-31

  EdU Imaging Kits (HF488) connect S-phase DNA synthesis measurement with microscopy and flow cytometry, making them useful for validating hepatocellular carcinoma biomarkers and drug-response hypotheses. Their antibody-free click-chemistry workflow preserves morphology and antigen-binding sites while providing quantitative proliferation endpoints.

• Sulfisomidine Workflows for Enzyme and Microbial Research

  2026-08-31

  Sulfisomidine, also known as sulfamethin, connects PABA-dependent microbial studies with hPON1 inhibition, oxidative stress regulation research, and environmental transformation workflows. This practical guide covers assay setup, concentration planning, time-course design, and troubleshooting for reproducible in vitro experiments.

• Lyso-Tracker Red for Lysosome Assays

  2026-08-30

  Lyso-Tracker Red enables live-cell visualization of acidic lysosomes during nanoparticle uptake, maturation, and intracellular trafficking. This practical workflow connects lysosomal imaging with the CLam/OVA vaccine-adjuvant study while clarifying how to distinguish acidification, compartment morphology, and lysosomal escape.

• HyperPFU™ high-fidelity DNA polymerase guide

  2026-08-29

  HyperPFU™ high-fidelity DNA polymerase is intended for accurate amplification of long, GC-rich, inhibitor-affected, or otherwise difficult DNA templates. It produces blunt-ended PCR products for cloning and sequencing, but is not the appropriate choice when a workflow requires 3′-A overhangs or preformed sticky ends.

• Tin Mesoporphyrin IX: A Causal HO Probe

  2026-08-28

  Tin Mesoporphyrin IX (chloride) enables researchers to move beyond HO-1 expression measurements and test whether heme oxygenase activity causally shapes ROS, heme catabolism, and viral phenotypes. This article develops an assay-to-mechanism framework grounded in recent HBV research and practical experimental controls.

• Gap26: Connexin 43 Mimetic Peptide Workflows

  2026-08-28

  Gap26 gives researchers a practical way to interrupt connexin 43-dependent communication while tracking calcium waves, ATP release, and mitochondrial transfer. This guide translates validated product parameters and a 2025 liver-graft study into cell, tissue, and in vivo workflows with controls that help distinguish channel blockade from nonspecific toxicity.

• Nullscript: A Histone Deacetylase Inhibitor

  2026-08-27

  Nullscript is a histone deacetylase inhibitor and close analog of scriptaid with an unusual transcriptional-facilitation profile. Product information reports approximately 46.8% in vivo myocardial infarct size reduction in a murine cardiac ischemia/reperfusion model, but no clinical evidence is available.

• Oridonin and Inflammation in Esophageal Cancer

  2026-08-27

  A 2025 mouse study links oridonin’s anti-esophageal-cancer effects to suppression of the TLR4/NF-κB/NLRP3 inflammasome axis. Its integrated use of histopathology, inflammatory biomarkers, hematology, qPCR, and western blotting provides a mechanistic framework for studying inflammation-driven tumor progression, while its findings remain preclinical and model dependent.

• M344 for Reliable Cell-Based Assays

  2026-08-26

  Learn how M344 (SKU A4105) supports reproducible cell viability, proliferation, differentiation, and cytotoxicity workflows. This scenario-driven guide connects mechanism, dosing, solubility, controls, and vendor-selection criteria for evidence-based laboratory decisions.

• γH2AX DNA Damage Detection Kit for DSB Workflows

  2026-08-26

  Turn radiation, nanoparticle, and genotoxicity experiments into spatially resolved measurements of DNA double-strand breaks with a red γ-H2AX signal and blue nuclear counterstain. This practical guide explains assay setup, quantitative imaging, repair kinetics, and troubleshooting for research models ranging from cultured cells to tissue sections.

• Degarelix Acetate and Rapid Prostate Cancer Control

  2026-08-25

  Laurence Klotz’s review examines degarelix acetate as a third-generation GnRH antagonist designed to achieve rapid medical castration without the testosterone surge associated with GnRH agonists. The paper’s clinical-trial synthesis highlights faster testosterone suppression, an early prostate-specific antigen response, and a safety profile broadly comparable to agonist therapy in advanced prostate cancer.

• Bone Transport, TGF-β1, and Diabetic Foot Ulcer Repair

  2026-08-25

  A 2026 rat study shows that bone transport accelerates ischemic diabetic foot ulcer healing through coordinated TGF-β1/TGFBR1 activation, angiogenesis, and immune regulation. Its inhibitor-based design and multimodal molecular analysis position TGF-β1 signaling as a mechanistic bridge between bone regeneration and chronic wound repair.

• Berbamine hydrochloride: NF-κB Research Workflows

  2026-08-24

  Build reproducible cytotoxicity and mechanism-focused assays with Berbamine hydrochloride across leukemia and hepatocellular carcinoma models. This workflow separates product-backed activity from exploratory ferroptosis hypotheses, helping researchers connect NF-κB and STAT3 readouts with the METTL16-SENP3-LTF framework.

8043 records 1/537 page Next 12345 下5页 Last page